Proinflammatory ATMs, which express CD11c+ (a classical marker for activated M1), are generally increased, hereby leading to inflammation and insulin resistance [28–31], resulting in a reduction of the relative number of CD206+ macrophages (alternatively activated or M2 macrophages), which are predominantly anti-inflammatory [32, 33]. The gene discussed is MRC1; the disease is Insulin resistance.